1. Home
  2. LSTA vs SURG Comparison

LSTA vs SURG Comparison

Compare LSTA & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • SURG
  • Stock Information
  • Founded
  • LSTA 1980
  • SURG 2006
  • Country
  • LSTA United States
  • SURG United States
  • Employees
  • LSTA N/A
  • SURG N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • SURG Advertising
  • Sector
  • LSTA Health Care
  • SURG Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • SURG Nasdaq
  • Market Cap
  • LSTA 31.2M
  • SURG 31.3M
  • IPO Year
  • LSTA N/A
  • SURG N/A
  • Fundamental
  • Price
  • LSTA $2.61
  • SURG $1.43
  • Analyst Decision
  • LSTA Strong Buy
  • SURG Buy
  • Analyst Count
  • LSTA 1
  • SURG 2
  • Target Price
  • LSTA $15.00
  • SURG $8.50
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • SURG 121.4K
  • Earning Date
  • LSTA 02-27-2025
  • SURG 03-11-2025
  • Dividend Yield
  • LSTA N/A
  • SURG N/A
  • EPS Growth
  • LSTA N/A
  • SURG N/A
  • EPS
  • LSTA N/A
  • SURG N/A
  • Revenue
  • LSTA N/A
  • SURG $83,602,653.00
  • Revenue This Year
  • LSTA N/A
  • SURG N/A
  • Revenue Next Year
  • LSTA N/A
  • SURG $59.69
  • P/E Ratio
  • LSTA N/A
  • SURG N/A
  • Revenue Growth
  • LSTA N/A
  • SURG N/A
  • 52 Week Low
  • LSTA $2.19
  • SURG $1.33
  • 52 Week High
  • LSTA $4.20
  • SURG $9.23
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • SURG 31.02
  • Support Level
  • LSTA $2.45
  • SURG $1.33
  • Resistance Level
  • LSTA $2.74
  • SURG $1.45
  • Average True Range (ATR)
  • LSTA 0.32
  • SURG 0.08
  • MACD
  • LSTA -0.05
  • SURG -0.01
  • Stochastic Oscillator
  • LSTA 16.48
  • SURG 16.67

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: